The Centre has informed the Supreme Court on Saturday that pharmaceutical company Zydus Cadila has concluded the clinical trials of its vaccine for the age group of 12 to 18 and the jabs will be available soon. Information about this vaccine, the Centre told Supreme Court in an affidavit filed on COVID-19 management. “Out of this requirement, 51.6 crore doses will be made available for administration by July 31, 2021, leaving a requirement of approximately 135 crore vaccine doses for complete vaccination to the eligible population,” the affidavit said. The Centre said it plans to procure 135 crore doses of various COVID-19 vaccines to be available between August to December this year. This includes 500 million doses of Covishield, 400 million doses of Covaxin, 100 million doses of Sputnik V vaccine and 50 million doses of Zydus Cadila.

Source: dna June 27, 2021 09:16 UTC